Aug 07 2025
A new study out of Oregon found that group psilocybin therapy led to significant improvements in quality of life for low-income individuals suffering from depression. The study, first reported by KLCC, involved 19 participants who each took part in two group psilocybin sessions. All participants were in stable housing and receiving therapy, with no personal …
Aug 07 2025
Two newly developed CBD products significantly outperformed a standard isolate capsule in terms of absorption and overall bioavailability, according to a new clinical trial published in the Journal of Cannabis Research. The study compared a bioavailability-enhanced CBD capsule and liquid formulation—both using surfactant/acid technology—to an unformulated CBD isolate capsule in 12 healthy male volunteers. Each …
Aug 07 2025
A new study finds that cannabidiol (CBD) may offer relief from a common and challenging side effect of Parkinson’s treatment without reducing the therapy’s motor benefits. Published in Progress in Neuro-Psychopharmacology and Biological Psychiatry, the study investigated the effects of CBD and a fluorinated CBD derivative (PECS-101) on L-DOPA-induced dyskinesia (LID)—a frequent complication of prolonged …
Aug 06 2025
New research shows that CBD may suppress metastasis in pancreatic cancer by disrupting molecular drivers of tumor cell invasion. A study published in IUBMB Life and conducted by researchers at Kyung Hee University has found that cannabidiol (CBD), a non-psychoactive compound derived from marijuana, may inhibit the spread of pancreatic ductal adenocarcinoma (PDAC) by targeting …
Aug 06 2025
A study analyzing data from over 25,000 adults finds that cannabis use in older individuals may be associated with cognitive benefits and brain network activity resembling that of younger people. Conducted using data from the UK Biobank and published on Research Square, the study explored how cannabis consumption intersects with age-related brain changes. Researchers examined …
Aug 05 2025
A new study published by the journal Psychological Research challenges long-held assumptions about chronic marijuana users and impulsive behavior, suggesting that habitual cannabis use may not significantly impair decision-making. Researchers from the University of Texas and Washington State University compared chronic cannabis users to non-users in a series of cognitive and physical tasks. In one …
Aug 04 2025
Cannabis and psychedelics were among the few substances rated positively for relieving symptoms of eating disorders (EDs), according to a new study published in JAMA Network Open. The study, which surveyed 7,648 individuals with self-reported EDs or disordered eating, found that while prescription psychotropics were often perceived as beneficial for overall mental health, they were …
Aug 04 2025
A new study from researchers at The Catholic University of Korea finds that cannabidiol (CBD) may provide a promising treatment for rosacea, particularly when combined with the commonly used antibiotic metronidazole (MET). Using an animal model of rosacea, scientists found that both CBD and MET significantly reduced redness, skin thickening, and mast cell infiltration. The …
Aug 03 2025
A new study shows that exposing cannabis plants to cooler temperatures significantly increases anthocyanin production—the compound responsible for purple pigmentation—without reducing flower weight or cannabidiol (CBD) content. Published in the Journal of Cannabis Research, the study was led by researchers from the Pennsylvania Department of Agriculture and the University of Wisconsin. Using a genetically stable …
Jul 31 2025
A new study published in the journal Academia Medicine finds that a significant number of people with inflammatory bowel disease (IBD) are turning to cannabis and cannabidiol (CBD) oil to help manage symptoms that conventional medications often fail to fully address. Researchers at University Hospitals Cleveland Medical Center and Case Western Reserve University surveyed 139 …
